Barclays PLC Globus Medical Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Globus Medical Inc stock. As of the latest transaction made, Barclays PLC holds 92,601 shares of GMED stock, worth $7.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,601

Previous 92,601 -0.0%

Holding current value

$7.72 Million

Previous $6.63 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$67.08 - $73.92 $29.5 Million - $32.5 Million	-439,883 Reduced 82.61%	92,601 $6.63 Million
Q2 2024 Aug 14, 2024	BUY	$49.79 - $68.85 $2.98 Million - $4.11 Million	59,757 Added 12.64%	532,484 $36.5 Million
Q1 2024 May 15, 2024	SELL	$51.15 - $56.52 $2.49 Million - $2.75 Million	-48,664 Reduced 9.33%	472,727 $25.4 Million
Q4 2023 Feb 15, 2024	SELL	$43.79 - $55.14 $4.78 Million - $6.03 Million	-109,271 Reduced 17.33%	521,391 $27.8 Million
Q3 2023 Nov 07, 2023	BUY	$49.1 - $62.37 $11.5 Million - $14.6 Million	233,459 Added 58.78%	630,662 $31.3 Million
Q2 2023 Aug 03, 2023	SELL	$52.61 - $59.54 $42.9 Million - $48.6 Million	-815,912 Reduced 67.26%	397,203 $23.6 Million
Q1 2023 May 04, 2023	BUY	$51.83 - $79.63 $62.2 Million - $95.6 Million	1,200,254 Added 9332.51%	1,213,115 $68.7 Million
Q4 2022 Feb 13, 2023	SELL	$58.4 - $75.53 $387,425 - $501,066	-6,634 Reduced 34.03%	12,861 $955,000
Q3 2022 Nov 03, 2022	SELL	$55.32 - $67.54 $346,192 - $422,665	-6,258 Reduced 24.3%	19,495 $1.16 Million
Q2 2022 Aug 12, 2022	BUY	$53.08 - $81.37 $317,630 - $486,918	5,984 Added 30.27%	25,753 $1.45 Million
Q1 2022 May 16, 2022	BUY	$63.68 - $75.54 $59,922 - $71,083	941 Added 5.0%	19,769 $1.46 Million
Q4 2021 Feb 14, 2022	SELL	$62.62 - $79.92 $4.47 Million - $5.7 Million	-71,357 Reduced 79.12%	18,828 $1.36 Million
Q3 2021 Nov 09, 2021	BUY	$76.41 - $84.06 $3.22 Million - $3.54 Million	42,139 Added 87.71%	90,185 $6.91 Million
Q2 2021 Aug 13, 2021	BUY	$61.85 - $77.53 $2.13 Million - $2.67 Million	34,464 Added 253.75%	48,046 $3.72 Million
Q1 2021 May 13, 2021	SELL	$60.05 - $67.74 $5.77 Million - $6.51 Million	-96,081 Reduced 87.61%	13,582 $838,000
Q4 2020 Feb 11, 2021	SELL	$48.89 - $65.87 $394,884 - $532,031	-8,077 Reduced 6.86%	109,663 $7.15 Million
Q3 2020 Nov 12, 2020	BUY	$45.26 - $57.82 $3.71 Million - $4.75 Million	82,079 Added 230.16%	117,740 $5.83 Million
Q2 2020 Aug 12, 2020	SELL	$39.81 - $55.61 $100,002 - $139,692	-2,512 Reduced 6.58%	35,661 $1.7 Million
Q1 2020 May 13, 2020	SELL	$35.06 - $59.45 $1.87 Million - $3.18 Million	-53,478 Reduced 58.35%	38,173 $1.62 Million
Q4 2019 Feb 10, 2020	BUY	$49.45 - $59.5 $256,497 - $308,626	5,187 Added 6.0%	91,651 $5.4 Million
Q3 2019 Nov 14, 2019	SELL	$40.41 - $52.32 $659,531 - $853,914	-16,321 Reduced 15.88%	86,464 $4.42 Million
Q2 2019 Aug 14, 2019	BUY	$39.3 - $48.41 $2.26 Million - $2.79 Million	57,602 Added 127.49%	102,785 $4.35 Million
Q1 2019 May 15, 2019	SELL	$38.08 - $49.41 $1.95 Million - $2.53 Million	-51,107 Reduced 53.08%	45,183 $2.23 Million
Q4 2018 Feb 14, 2019	BUY	$41.38 - $57.44 $1.18 Million - $1.64 Million	28,631 Added 42.32%	96,290 $4.17 Million
Q3 2018 Nov 14, 2018	BUY	$50.24 - $56.76 $1.86 Million - $2.1 Million	37,073 Added 121.21%	67,659 $3.84 Million
Q2 2018 Aug 14, 2018	SELL	$47.96 - $57.41 $152,704 - $182,793	-3,184 Reduced 9.43%	30,586 $1.54 Million
Q1 2018 May 15, 2018	BUY	$42.75 - $51.73 $146,247 - $176,968	3,421 Added 11.27%	33,770 $1.68 Million
Q4 2017 Feb 14, 2018	SELL	$28.86 - $41.64 $85,541 - $123,420	-2,964 Reduced 8.9%	30,349 $1.25 Million
Q3 2017 Nov 14, 2017	BUY	$28.28 - $30.85 $942,091 - $1.03 Million	33,313	33,313 $990,000

Others Institutions Holding GMED

# of Institutions

480

Shares Held

104M

Call Options Held

183K

Put Options Held

57.3K

View Full List

About GLOBUS MEDICAL INC

Ticker GMED
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 77,037,200
Market Cap $6.43B
Description
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...

More about GMED

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account